Also known as: Firdapse / 3,4-DAP
Amifampridine (3,4-diaminopyridine) is a potassium channel blocker used in the treatment of Lambert-Eaton myasthenic syndrome (LEMS). It enhances acetylcholine release at the neuromuscular junction. Mediocon Inc supplies pharmaceutical-grade Amifampridine for rare disease and specialty neurological manufacturers.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | 98.0% – 101.0% |
| Loss on Drying | NMT 1.0% |
| Melting Point | 215°C – 220°C |
| Heavy Metals | NMT 10 ppm |
| pH | N/A |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 1 kg foil pouches / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Amifampridine (CAS 54-96-6) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Amifampridine is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance